Lorynn Teela

48 Chapter 2 Supplement 2 - (continued) First author Year Country N Disease group Age (min) Age (max) Used method* Setting Corbo [51] 1985 United States 14 Patients on a ventilator 12 16;9 1 Clinical care Corsano [52] 2015 Italy 27 Multiple disease groups 6 15 1 Clinical care Coyne [53] 2006 United Kingdom 11 Multiple disease groups 7 14 1 Clinical care Coyne [54] 2006 United Kingdom 11 Multiple disease groups NR NR 1,5 Clinical care Coyne [55] 2016 Ireland 20 Oncology 7 16 1 Clinical care Coyne [56] 2014 Ireland 20 Oncology 7 16 1 Clinical care Coyne [57] 2011 Ireland 55 Multiple disease groups 7 18 1,2 Clinical care Coyne [58] 2012 Ireland 55 Multiple disease groups 7 18 1,5,8 Clinical care Crnkovic [59] 2009 Croatia 190 Multiple disease groups 7 19 5 Clinical care Dagg [60] 2020 Canada 7 Surgery 13 17 1 Clinical care Davies [61] 2007 United States 4 Palliative care 6 17 1 Clinical care Davies [62] 2005 United States 4 Palliative care 6 19 1 Clinical care Deatrick [63] 1984 United States 24 Surgery NR NR 1 Clinical care Dedding [64] 2015 The Netherlands 30 Diabetes 8 12 1,2 Clinical care Dekking [65] 2015 The Netherlands 2 Oncology 13 18 1 Research Dell’Api [66] 2007 Canada 5 Chronic pain 10 17 1 Clinical care Dellenmark-Blom [67] 2016 Sweden 18 Surgery 8 17 2 Intervention development Di Ciommo [68] 2012 Italy 20 Metabolic diseases 8 23 1 Clinical care Dixon-Woods [69] 2002 United Kingdom 21 Asthma 8 16 1 Clinical care Dowler [70] 2016 United Kingdom 25 Hospital admission NR NR 3 Clinical care Earle [71] 2006 Canada 5 Multiple disease groups 4;5 17 1 Clinical care Ekra [72] 2015 Norway 9 Diabetes 5 12 1,4 Clinical care Elliott [73] 2019 Canada 2 Juvenile Idiopathic Arthritis NR NR 1,2 Research Erdem Atak [74] 2019 Cyprus 31 Multiple disease groups 5 16 3 Clinical care Fahner [75] 2020 The Netherlands 13 Palliative care 11 18 1,2 Intervention development

RkJQdWJsaXNoZXIy MTk4NDMw